NEW YORK, July 09, 2019 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links provided. There is no cost or obligation to you.
Intersect ENT, Inc. (NASDAQGM: XENT)
Class Period: August 1, 2018 - May 6, 2019
Lead Plaintiff Deadline: July 15, 2019
Join the action: https://www.zlk.com/pslra-1/intersect-ent-inc-loss-form?wire=3
About the lawsuit: Throughout the class period, Intersect ENT, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) Intersect lacked adequate reimbursement representatives to ensure physicians had access to SINUVA, Intersect’s sinus implant; (2) Intersect’s sales force would focus on ensuring reimbursement; (3) Intersect’s sales representatives were less focused on driving sales; (4) physicians were less likely to adopt Intersect’s SINUVA due to transaction costs associated with seeking reimbursement; (5) Intersect would increase staffing to address these issues; and (6) as a result of the foregoing, defendants’ positive statements about Intersect’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
To learn more about the Intersect ENT, Inc. class action contact jlevi@levikorsinsky.com.
Livent Corporation (NYSE: LTHM)
Class Period: on behalf of persons and entities that purchased or otherwise acquired Livent securities pursuant and/or traceable to initial public offering on or around October 11, 2018.
Lead Plaintiff Deadline: July 22, 2019
Join the action: https://www.zlk.com/pslra-1/livent-corporation-loss-form?wire=3
About the lawsuit: During the class period, Livent Corporation allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) a supply contract with Nemaska Lithium Inc. had been terminated; (2) as a result, the Company would be forced to fulfill its customer contracts using alternative vendors at reduced revenues and lower margins; (3) the Company had a long-standing contract to supply lithium hydroxide to a customer at a much lower price than any of the Company's existing contracts; (4) the Company's margins were squeezed due to the customer's increased orders; and (5) as a result of the foregoing, Defendants positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.
To learn more about the Livent Corporation class action contact jlevi@levikorsinsky.com.
Eros International Plc (NYSE: EROS)
Class Period: July 28, 2017 - June 5, 2019
Lead Plaintiff Deadline: August 20, 2019
Join the action: https://www.zlk.com/pslra-1/eros-international-plc-loss-form?wire=3
About the lawsuit: Eros International Plc allegedly made materially false and/or misleading statements during the class period and/or failed to disclose that: (1) Eros and its executives engaged in a scheme to use related-party transactions to fabricate receivables that they reported in Eros’s public financial disclosures; (2) because of this scheme, Eros’s financial position was weaker than what the Company disclosed; (3) consequently, the Company’s Indian subsidiary, Eros International Media Ltd (“EIML”), missed loan payments and had its credit downgraded; and (4) due to the foregoing, Defendants’ statements about Eros’s receivables, business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.
To learn more about the Eros International Plc class action contact jlevi@levikorsinsky.com.
Anheuser-Busch Inbev Sa/Nv (NYSE: BUD)
Class Period: March 1, 2018 - October 24, 2018
Lead Plaintiff Deadline: August 20, 2019
Join the action: https://www.zlk.com/pslra-1/anheuser-busch-inbev-sa-nv-loss-form?wire=3
According to the filed complaint, Defendants issued a steady stream of materially false and misleading reassurances about Anheuser Busch’s deleveraging efforts, cost cutting measures, EBITDA growth, the sufficiency of its liquidity and its debt maturity profile during the Class Period. These positive statements by Defendants created a false impression and materially misled investors about the Company’s finances, including the sustainability of Anheuser-Busch’s dividends. Once Defendants chose to speak about Anheuser-Busch’s finances, they had a duty to speak completely and truthfully, including speaking about those factors that were then having a material adverse effect on the Company’s deleveraging efforts.
To learn more about the Anheuser-Busch Inbev Sa/Nv class action contact jlevi@levikorsinsky.com.
You have until the lead plaintiff deadlines to request the court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com